Allan DS - Search Results

1

Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.

Keeney M, Allan DS, Lohmann RC, Yee IH. Keeney M, et al. Among authors: allan ds. Lab Hematol. 2005;11(2):118-23. doi: 10.1532/LH96.04048. Lab Hematol. 2005. PMID: 16024335

2

Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.

Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, Sutherland DR, Chin-Yee IH. Allan DS, et al. Bone Marrow Transplant. 2002 Jun;29(12):967-72. doi: 10.1038/sj.bmt.1703575. Bone Marrow Transplant. 2002. PMID: 12098064

3

Undetectable leukemic blasts and absence of NOD/SCID leukemia-initiating cells in cord blood from a case of maternal AML.

Allan DS, Gallacher L, Keeney M, Bhatia M, Chin-Yee I, Xenocostas A. Allan DS, et al. Bone Marrow Transplant. 2005 Aug;36(3):269-70. doi: 10.1038/sj.bmt.1705035. Bone Marrow Transplant. 2005. PMID: 15937500 No abstract available.

4

Catastrophic microangiopathy induced by high-titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis.

Khakhar AK, Chan NG, Allan DS, Chakrabarti S, McAlister VC. Khakhar AK, et al. Among authors: allan ds. Haemophilia. 2005 Nov;11(6):623-8. doi: 10.1111/j.1365-2516.2005.01145.x. Haemophilia. 2005. PMID: 16236113

5

Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.

Iqbal T, Rajagopal T, Halpenny M, Yang L, Martin L, Giulivi A, McDiarmid S, Huebsch L, Allan DS. Iqbal T, et al. Among authors: allan ds. Exp Hematol. 2008 Apr;36(4):506-12. doi: 10.1016/j.exphem.2007.12.005. Epub 2008 Feb 8. Exp Hematol. 2008. PMID: 18261841 Free article.

6

Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.

Labonté L, Li Y, Yang L, Gillingham A, Halpenny M, Giulivi A, Sills T, Evans K, Zanke B, Allan DS. Labonté L, et al. Among authors: allan ds. Exp Hematol. 2009 Jun;37(6):673-8. doi: 10.1016/j.exphem.2009.02.010. Exp Hematol. 2009. PMID: 19463769 Free article.

7

Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D. Tay J, et al. Among authors: allan ds. J Clin Oncol. 2020 May 1;38(13):1463-1473. doi: 10.1200/JCO.19.01836. Epub 2020 Feb 21. J Clin Oncol. 2020. PMID: 32083994 Clinical Trial.

8

Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation.

Kekre N, Christou G, Mallick R, Tokessy M, Tinmouth A, Tay J, Allan DS. Kekre N, et al. Among authors: allan ds. Transfusion. 2012 Sep;52(9):2049-54. doi: 10.1111/j.1537-2995.2011.03552.x. Epub 2012 Feb 10. Transfusion. 2012. PMID: 22321053

9

Ciprofloxacin-associated hemolytic-uremic syndrome.

Allan DS, Thompson CM, Barr RM, Clark WF, Chin-Yee IH. Allan DS, et al. Ann Pharmacother. 2002 Jun;36(6):1000-2. doi: 10.1345/aph.1A350. Ann Pharmacother. 2002. PMID: 12022900

10

Maintaining high autopsy rates in a Canadian blood and marrow transplant program: preserving a diagnostic and research tool.

Allan DS, Bélanger R, Busque L, Cohen S, Fish D, Roy DC, Roy J. Allan DS, et al. Bone Marrow Transplant. 2005 Apr;35(8):781-5. doi: 10.1038/sj.bmt.1704869. Bone Marrow Transplant. 2005. PMID: 15735662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters